Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

Benzyl salicylate was shown to be a skin sensitiser in a local lymph node assay according to OECD 429.


Migrated from Short description of key information:
Sensitising to skin (OECD 429)

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

Benzyl salicylate was shown not to be a skin sensitiser in a local lymph node assay according to OECD 429. The EC₃ value was triggered at test concentration of 2.9 %, thus classification as a skin sensitiser is required.